The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 02, 2024

Filed:

Aug. 24, 2020
Applicants:

Genethon, Evry, FR;

Royal Holloway and Bedford New College, Egham, GB;

Association Institut DE Myologie, Paris, FR;

Institut National DE LA Sante ET DE LA Recherche Medicale, Paris, FR;

Centre National DE LA Recherche Scientifique, Paris, FR;

Sorbonne Universite, Paris, FR;

Centre Hospitalier Universitaire DE Nantes, Nantes, FR;

Nantes Universite, Nantes, FR;

Inventors:

George Dickson, London, GB;

Thomas Voit, Boullay les Troux, FR;

Philippe Moullier, Nantes, FR;

Caroline Le Guiner, Granchamp des Fontaines, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/17 (2006.01); A61K 48/00 (2006.01); C12N 7/00 (2006.01); C12N 15/86 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1719 (2013.01); A61K 48/005 (2013.01); A61K 48/0058 (2013.01); A61K 48/0075 (2013.01); C12N 7/00 (2013.01); C12N 15/86 (2013.01); C12N 2750/14132 (2013.01); C12N 2750/14143 (2013.01); C12N 2750/14171 (2013.01); C12N 2840/007 (2013.01);
Abstract

A composition comprising a gene therapy product for use in the treatment of a dystrophic disease in a subject, advantageously in humans, wherein: the gene therapy product comprises a nucleic acid sequence encoding a functional microdystrophin; the composition is systemically administered.


Find Patent Forward Citations

Loading…